With a drop of 3.22%, the shares of the health operator Hapvida (HAPV3) are one of the biggest drops of the day, quoted at R$ 9.61. The reason for the drop is that market analysts expect that the results that the company is expected to release on the 17th of this month will show a weak first quarter of the year. In addition, a possible increase in unemployment should affect the operator’s customer base.
According to Citi bank, what most affected the company’s business in the first three months of the year was the explosion of cases of the ômicron variant, of covid-19. With more patients to see, costs go up. But with the drop in cases observed from March onwards, the company’s business should improve.
Check out what the analysts say:
The American bank Citi cut from R$15 to R$14 the target price of the health plan operator and hospital owners, but maintained the purchase recommendation.
In view of the expectation of improvement, XP also recommends a purchase for Hapvida, with a target price of R$19 per share. The bank believes that the company should continue to consolidate itself in the market. “The merger with Grupo Notredame Intermédica should create considerable synergies”, XP published in a report.
Why, then, are stocks down today?
It is a consequence of the more deteriorated macroeconomic scenario, according to XP. As a large part of the company’s national beneficiary base is made up of employees who enter the agreement as beneficiaries of the companies they work for, Hapvida’s performance is closely linked to the evolution of unemployment in the country.
As the employment and unemployment data from Caged (General Registry of Employed and Unemployed) will be released tomorrow, the market must be predicting bad results.
On Friday (29) will also be released the data on the unemployment rate of the PNAD (National Household Sample Survey) Continuous, IBGE (Brazilian Institute of Geography and Statistics).